Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011 Oct;96(10):e41-2.
doi: 10.3324/haematol.2011.048991.

Evaluation of overall survival according to myelodysplastic syndrome-specific comorbidity index in a large series of myelodysplastic syndromes

Massimo Breccia, Vincenzo Federico, Giuseppina Loglisci, Adriano Salaroli, Alessandra Serrao, Giuliana Alimena
Comment

Evaluation of overall survival according to myelodysplastic syndrome-specific comorbidity index in a large series of myelodysplastic syndromes

Massimo Breccia et al. Haematologica. 2011 Oct.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Della Porta MG, Malcovati L, Strupp C, Ambaglio I, Kuendgen A, Zipperer E, et al. Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodys-plastic syndrome. Haematologica. 2011;96(3):441–9. - PMC - PubMed
    1. Cazzola M. Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Haematologica. 2011;96(3):349–52. - PMC - PubMed
    1. Breccia M, Federico V, Latagliata R, Mercanti C, D’Elia GM, Cannella L, et al. Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients. Leuk Res. 2011;35(2):159–62. - PubMed
    1. Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol. 2007;25(33):3503–10. - PubMed